IOM Seeks Comment on Industry-Funded Trial Data-Sharing Plan

Drug Industry Daily
A A
To foster discussion on what level of transparency on clinical trials is appropriate, the Institute of Medicine (IOM) is seeking comment on a wide range of proposals that would encourage clinical data sharing.

To View This Article:

Login

Subscribe To Drug Industry Daily